SpaceX has delayed the launch of its pioneering private spacewalk mission due to a ground-side helium leak. Originally set for August 27, the mission will now launch on August 28, marking a significant milestone in commercial space exploration.
SpaceX Postpones Launch of Historic Private Spacewalk Mission Due to Helium Leak; Rescheduled for August 28
SpaceX has postponed the rocket launch intended to convey four private astronauts to space. According to Bloomberg, this mission, designed to perform the world's first commercial spacewalk, is a groundbreaking endeavor.
Sarah Gillis, one of SpaceX's two chief engineers, stated that the launch, initially scheduled for early August 27, was scrubbed to investigate a ground-side helium leak. SpaceX announced that the subsequent launch window will only occur on August 28.
Jared Isaacman, an entrepreneur, is aboard the Polaris Dawn mission. Isaacman previously launched into orbit with SpaceX in 2021 and provided funding for the flight and its development. Scott "Kidd" Poteet, Isaacman's friend and former Air Force pilot, accompanies him on the flight. The two chief SpaceX engineers, Gillis and Anna Menon, are
The mission's signature moment is scheduled for the third day of the flight. Isaacman and Gillis intend to exit an open port on their Crew Dragon spacecraft and conduct individual spacewalks. The two will be tethered to the vehicle and venture out for approximately 15 to 20 minutes each.
SpaceX is enthusiastic about testing the new capability, but it is still being determined how it intends to integrate spacewalking into future missions.
“I think we will be really interested to see where the company takes it,” Gillis said in an interview before launch. “Obviously, this is the first step, and this is a really important step.”
Polaris Dawn Crew to Test SpaceX’s New Suits During Record-Breaking Mission Beyond 1,400 km Altitude
The entire crew will don SpaceX's new space suits, as the whole interior of the Crew Dragon will be exposed to the vacuum of space during the maneuver, despite only Gillis and Isaacman exiting the spacecraft. The process, which includes discharging the spacecraft's atmosphere and resealing the vehicle, is expected to last approximately two hours.
Polaris Dawn intends to perform several secondary objectives and set several spaceflight records in addition to the mission's primary focus, the spacewalk. During the initial flight segment, the Crew Dragon spacecraft will ascend to a height of 1,400 kilometers above Earth, marking the most significant distance humans have traveled into space since the Apollo astronauts landed on the moon. If the mission succeeds, Menon and Gillis will hold the record for the women who have traveled the furthest from Earth.
Due to their distance, the personnel will be subjected to a significantly higher radiation environment than the average astronaut encounters while traveling to the International Space Station in low-Earth orbit. This will enable SpaceX to gather essential research regarding the human body's response to the space environment.


China Says U.S. Shares Responsibility for AI Governance
Tabletop particle accelerator could transform medicine and materials science
China vs. NASA: The New Moon Race and What's at Stake by 2030
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Pi Network Price Holds $0.087 as Protocol 28 Mainnet Upgrade Nears
AMD Hits $1 Trillion as BofA Raises Price Target to $720
Neuralink Expands Brain Implant Trials with 12 Global Patients
TSMC Accelerates 2nm Expansion as AI Chip Demand Surges
OpenAI Scraps GPT-6.1 Astra Launch Over Safety Concerns
US Appeals Court Upholds Anthropic AI Supply Chain Ban
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Trump Administration Releases New UFO Files and Apollo Mission Records
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
DaVoice Sues Perplexity AI Over Trade Secrets
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 



